Allogene Therapeutics Inc (NAS:ALLO)
$ 2.14 -0.05 (-2.28%) Market Cap: 459.18 Mil Enterprise Value: 269.53 Mil PE Ratio: 0 PB Ratio: 0.99 GF Score: 37/100

Allogene Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 05, 2020 / 02:00PM GMT
Release Date Price: $42.63 (-0.86%)
Operator

Good day, and welcome to the Allogene Therapeutics, Inc. 2020 Annual Meeting of Shareholders.

It is now my pleasure to turn today's meeting over to Dr. David Chang, Chief Executive Officer of Allogene Therapeutics. Dr. Chang, the floor is yours.

David D. Chang
Allogene Therapeutics, Inc. - Co-Founder, President, CEO & Director

Good morning. This is David Chang, and I'm the Chief Executive Officer and the director of Allogene Therapeutics. I'm very happy to welcome you to the Allogene 2020 Annual Meeting of Stockholders. As you know, we are hosting today's meeting through a virtual online platform for health and safety reasons due to the COVID-19 pandemic. With that in mind, I want to thank you for taking the time to join us and hope you all safe and well.

In order to conduct an orderly meeting, we ask that you follow the rules of conduct, which are available on the meeting materials online. While the meeting is virtual only, stockholders of record will have the opportunity to submit questions or comments through the text box located on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot